Zenas BioPharma, Inc.
ZBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $405,676 | $330,226 | $342,260 |
| - Cash | $115,565 | $44,006 | $196,554 | $319,742 |
| + Debt | $180 | $1,008 | $1,225 | $1,003 |
| Enterprise Value | – | $362,678 | $134,897 | $23,521 |
| Revenue | $0 | $0 | $10,000 | $5,000 |
| % Growth | – | -100% | 100% | – |
| Gross Profit | -$5,000 | -$43,027 | $10,000 | $5,000 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$51,488 | -$55,151 | -$33,755 | -$55,590 |
| % Margin | – | – | -337.6% | -1,111.8% |
| Net Income | -$51,499 | -$52,223 | -$33,573 | -$52,604 |
| % Margin | – | – | -335.7% | -1,052.1% |
| EPS Diluted | -1.22 | -1.25 | -0.8 | -1.26 |
| % Growth | 2.4% | -56.2% | 36.5% | – |
| Operating Cash Flow | -$41,125 | -$41,743 | -$37,051 | -$38,554 |
| Capital Expenditures | $0 | $0 | -$18 | -$74 |
| Free Cash Flow | -$41,125 | -$41,743 | -$37,069 | -$38,628 |